CClinicalTrials.gg
CompletedNCT03406312EDSUpdated Dec 1, 2021

Validation of a Diagnostic Tool for Postprandial Hypoglycaemia in Patients After Roux en Y Gastric Bypass Surgery

An observational study in Post Prandial Hypoglycemia, sponsored by University Ghent. Completed at 1 site in Belgium. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-12-01.

Sponsored by University Ghent · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
40
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Roux-en-Y gastric bypass (RYGB) leads to weight reduction but has also some unwanted side effects. A part of this population will develop postprandial reactive hypoglycemia (PPRH). At this moment no validated diagnostic tool exists for PPRH. The aim of this study is to prove an association between the Sigstad´s Score and the lowest postprandial glucose level in patients after RYGB surgery. This is investigated using a liquid mixed meal tolerance test (LMMTT). As a secondary hypothesis, associations between Edinburgh Hypoglycemia Scale (EHS) and postprandial glucose levels are investigated. Furthermore, changes of insulin and GLP-1 levels during the test are analysed. Patient characteristics including co-morbidities are studied as possible influencing parameters. Moreover, a healthy control group is included to validate the results. Finally, a flowchart/diagnostic method will be proposed for diagnosing patients who had a RYBG surgery with symptoms suggestive of PPRH. Besides the LMMTT, participants at the Ghent University Hospital will undergo additional tests such as a solid mixed meal tolerance test (SMMTT) and continuous glucose monitoring (CGM). Associations between Sigstad Score, EHS and the lowest glucose measured during CGM and SMMTT will be investigated and compared to the results of the LMMTT.

02

Conditions studied

  • Post Prandial Hypoglycemia

Browse trials for

Keywords

  • Roux en Y Gastric Bypass Surgery, Hypoglycemia, Postprandial
03

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

In total 100 GBS patients which will be recruited over multiple sites in Germany, Great Britain, Belgium and Denmark.

Belgium will be the only site performing the solid mixed meal tolerance test and the continuous glucose monitoring additional to the liquid mixed meal tolerance test. All other sites will only do the liquid mixed meal tolerance test.

In total 20 control patients (10 with a BMI 18-25 kg/m² and 10 with a BMI > 30 kg/m²) will be recruited. These will be recruited in Belgium (Ghent University Hospital) and the patients will undergo a liquid mixed meal tolerance test, a solid mixed meal tolerance test and a continuous glucose monitoring

Inclusion criteria

  • for GBS group: primary GBS, 1-5 years post surgery
  • for control group: 10 subjects BMI 18-25kg/m² and 10 subjects BMI >30 kg/m²

Exclusion criteria

Exclusion Criteria:

  • Antidiabetic medication (oral or injectable), somatostatin analogs
  • Use of systemic corticosteroids
  • for GBS group: Any surgery after RYGB affecting anatomic integrity of the bypass, e.g. banding, conversion of the proximal and/or distal anastomosis
  • for GBS group: Any surgery before RYGB affecting anatomic integrity of the bypass, e.g. banding, conversion of the proximal and/or distal anastomosis, sleeve gastrectomy
  • Known renal insufficiency: CDK ≥ 4
  • Known liver cirrhosis
  • Known cardiovascular risk: NYHA ≥ III
  • Mental incapacity
  • Language barriers with inability to communicate with research staff
  • Anemia Hb \< 6.2 mmol/l (10.0 g/dl)
  • Cancer within \< 5 years
  • Pregnancy
  • Allergy to the Fresubin E
  • Allergy to components of the solid mixed meal (white bread, cheese spread, margarine, orange)
04

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
40 participants (actual)
Patient registry
No

Groups and cohorts

  • Gastric Bypass Surgery population

    liquid mixed meal tolerance test, solid mixed meal tolerance test, continuous glucose monitoring

    Diagnostic Test: Post Prandial Hypoglycemia test

  • Control population

    liquid mixed meal tolerance test, solid mixed meal tolerance test, continuous glucose monitoring

    Diagnostic Test: Post Prandial Hypoglycemia test

Interventions

  • Diagnostic testPost Prandial Hypoglycemia test

    three test assessing hypoglycemia will be used: liquid mixed meal tolerance test, solid mixed meal tolerances test, continuous glucose monitoring

05

What researchers measure

Primary outcomes

  1. Association between Sigstad's score and the lowest postprandial glucose levels

    we are investigating whether there is an association between the Sigtad's score and the lowest glucose levels postprandialy

    Time frame: end 2018

Secondary outcomes

  1. Association between Ediinburgh Hypoglycemia scale and the lowest postprandial glucose levels

    we are investigating whether there is an association between the Ediinburgh Hypoglycemia scale and the lowest glucose levels postprandialy

    Time frame: end 2018

  2. flow chart for diagnosis of postprandial reactive hypoglyceamia

    Proposing a flowchart/diagnostic method for the diagnosis of postprandial reactive hypoglycemic syndrome which occurs in people who underwent a gastric bypass surgery

    Time frame: end 2018

06

Study locations

1 site
  • Endocrinology, UZ Ghent Hospital
    Ghent, 9000, Belgium
07

Registry details

Key details

Study ID
NCT03406312
Lead sponsor
University Ghent
Responsible party
Sponsor
First posted
Jan 23, 2018
Start date
Jun 1, 2017
Primary completion
May 5, 2020
Completion
May 5, 2020
Last update
Dec 1, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion